Beverley Cuddy, a 63-year-old woman from Worcestershire, has described how the weight-loss drug Mounjaro has 'changed her life' after she lost a remarkable eight stone (51kg), or about 40% of her body weight.
She began taking the medication in April 2023, and it has helped her feel fuller for longer, which has also led to a change in her spending habits, as she no longer buys as much at supermarkets or on takeaways.
Ms.
Cuddy said that while a recent price hike, which could see the highest dose jump from £122 to £330 per month, would have 'frightened' her as a first-time user, she believes people should look at 'price versus value.' She felt fortunate to have been an early user of the drug when it was more affordable, noting that it was 'expensive but not compared to surgery.' Before taking Mounjaro, she described herself as feeling unwell and dependent on others.
Her health has since improved, and she feels a renewed sense of optimism.
However, the potential price increase has alarmed health professionals.
Dr.
Leyla Hannbeck, head of the Independent Pharmacies Association, has issued a stark warning that the rising cost could drive people to purchase the drug from illegitimate and potentially 'dangerous' websites, including those in China.
Dr.
Hannbeck urged people to seek advice from their pharmacist for legitimate alternatives, emphasizing the risks associated with unregulated products.
Ms.
Cuddy's story serves as a powerful testament to the drug's life-changing potential, but also highlights a serious concern about accessibility and safety for future users.
She began taking the medication in April 2023, and it has helped her feel fuller for longer, which has also led to a change in her spending habits, as she no longer buys as much at supermarkets or on takeaways.
Ms.
Cuddy said that while a recent price hike, which could see the highest dose jump from £122 to £330 per month, would have 'frightened' her as a first-time user, she believes people should look at 'price versus value.' She felt fortunate to have been an early user of the drug when it was more affordable, noting that it was 'expensive but not compared to surgery.' Before taking Mounjaro, she described herself as feeling unwell and dependent on others.
Her health has since improved, and she feels a renewed sense of optimism.
However, the potential price increase has alarmed health professionals.
Dr.
Leyla Hannbeck, head of the Independent Pharmacies Association, has issued a stark warning that the rising cost could drive people to purchase the drug from illegitimate and potentially 'dangerous' websites, including those in China.
Dr.
Hannbeck urged people to seek advice from their pharmacist for legitimate alternatives, emphasizing the risks associated with unregulated products.
Ms.
Cuddy's story serves as a powerful testament to the drug's life-changing potential, but also highlights a serious concern about accessibility and safety for future users.
